John A. Ward

Array ( [id] => 5501739 [patent_doc_number] => 20090162427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'VACCINES USING NUCLEIC ACID-LIPID COMPLEXES' [patent_app_type] => utility [patent_app_number] => 12/399896 [patent_app_country] => US [patent_app_date] => 2009-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20143 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162427.pdf [firstpage_image] =>[orig_patent_app_number] => 12399896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479548 [patent_doc_number] => 20090202505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Rescue of Photoreceptors by Intravitreal Administration of an Expression Vector Encoding a Therapeutic Protein' [patent_app_type] => utility [patent_app_number] => 12/366596 [patent_app_country] => US [patent_app_date] => 2009-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11262 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202505.pdf [firstpage_image] =>[orig_patent_app_number] => 12366596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6189872 [patent_doc_number] => 20110126304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'METHOD FOR DISTINGUISHING SECRETORY GRANULES OF DIFFERENT AGES' [patent_app_type] => utility [patent_app_number] => 12/863365 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12704 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20110126304.pdf [firstpage_image] =>[orig_patent_app_number] => 12863365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134955 [patent_doc_number] => 20110008784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'METHODS AND COMPOSITIONS FOR IDENTIFYING UNDIFFERENTIATED STEM CELLS AND ASSESSING CELL HEALTH' [patent_app_type] => utility [patent_app_number] => 12/812489 [patent_app_country] => US [patent_app_date] => 2009-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 29049 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008784.pdf [firstpage_image] =>[orig_patent_app_number] => 12812489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580544 [patent_doc_number] => 20090175890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'USE OF IMMATURE DENDRITIC CELLS TO SILENCE ANTIGEN SPECIFIC CD8+ T CELL FUNCTION' [patent_app_type] => utility [patent_app_number] => 12/346285 [patent_app_country] => US [patent_app_date] => 2008-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10558 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175890.pdf [firstpage_image] =>[orig_patent_app_number] => 12346285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054668 [patent_doc_number] => 20110111028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Composition and Methods For Repair of Connective Tissue' [patent_app_type] => utility [patent_app_number] => 12/736314 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5885 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20110111028.pdf [firstpage_image] =>[orig_patent_app_number] => 12736314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5381691 [patent_doc_number] => 20090193530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Animals, cells and methods for production of detectably-labeled antibodies' [patent_app_type] => utility [patent_app_number] => 12/316433 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7502 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20090193530.pdf [firstpage_image] =>[orig_patent_app_number] => 12316433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5381691 [patent_doc_number] => 20090193530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Animals, cells and methods for production of detectably-labeled antibodies' [patent_app_type] => utility [patent_app_number] => 12/316433 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7502 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20090193530.pdf [firstpage_image] =>[orig_patent_app_number] => 12316433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186810 [patent_doc_number] => 20120115896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'ISOGENIC HUMAN CELL LINES COMPRISING MUTATED CANCER ALLELES AND PROCESS USING THE CELL LINES' [patent_app_type] => utility [patent_app_number] => 13/132737 [patent_app_country] => US [patent_app_date] => 2008-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 21326 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115896.pdf [firstpage_image] =>[orig_patent_app_number] => 13132737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8340328 [patent_doc_number] => 08242253 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-14 [patent_title] => 'Nucleotide sequence of shrimp actin promoter and its use in genetic transformation biotechnology' [patent_app_type] => utility [patent_app_number] => 12/274627 [patent_app_country] => US [patent_app_date] => 2008-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 11076 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12274627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8630152 [patent_doc_number] => 08362223 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Hemopoietin receptor protein, NR10' [patent_app_type] => utility [patent_app_number] => 12/253506 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23188 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12253506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6549751 [patent_doc_number] => 20100233144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'METHOD FOR OPTIMIZING BLOOD CELL TRANSPLANTS' [patent_app_type] => utility [patent_app_number] => 12/682643 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4216 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233144.pdf [firstpage_image] =>[orig_patent_app_number] => 12682643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952218 [patent_doc_number] => 20110033388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'IMAGEABLE RODENT MODEL OF ASTHMA' [patent_app_type] => utility [patent_app_number] => 12/681348 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7228 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033388.pdf [firstpage_image] =>[orig_patent_app_number] => 12681348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5435026 [patent_doc_number] => 20090169612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes' [patent_app_type] => utility [patent_app_number] => 12/242526 [patent_app_country] => US [patent_app_date] => 2008-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 29478 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169612.pdf [firstpage_image] =>[orig_patent_app_number] => 12242526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8114415 [patent_doc_number] => 08158419 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Transgenic non-human animals for producing chimeric antibodies' [patent_app_type] => utility [patent_app_number] => 12/239493 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 100 [patent_figures_cnt] => 116 [patent_no_of_words] => 89957 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158419.pdf [firstpage_image] =>[orig_patent_app_number] => 12239493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5571623 [patent_doc_number] => 20090255002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Transgenic Non-Human Animals For Producing Chimeric Antibodies' [patent_app_type] => utility [patent_app_number] => 12/239523 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 101 [patent_figures_cnt] => 101 [patent_no_of_words] => 90274 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20090255002.pdf [firstpage_image] =>[orig_patent_app_number] => 12239523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5322853 [patent_doc_number] => 20090060843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Non-Invasive In Vivo Imaging and Methods for Treating Type I Diabetes' [patent_app_type] => utility [patent_app_number] => 12/199473 [patent_app_country] => US [patent_app_date] => 2008-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11990 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20090060843.pdf [firstpage_image] =>[orig_patent_app_number] => 12199473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7573055 [patent_doc_number] => 20110268711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'PANCREATIC STELLATE CELL SPECIFIC PROMOTER AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/674414 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10904 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20110268711.pdf [firstpage_image] =>[orig_patent_app_number] => 12674414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8629906 [patent_doc_number] => 08361978 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Use of herpes vectors for tumor therapy' [patent_app_type] => utility [patent_app_number] => 12/194872 [patent_app_country] => US [patent_app_date] => 2008-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 9552 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12194872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11720698 [patent_doc_number] => 09693539 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-04 [patent_title] => 'HCO32 and HCO27 and related examples' [patent_app_type] => utility [patent_app_number] => 12/672883 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 27789 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12672883 [rel_patent_id] =>[rel_patent_doc_number] =>)